RIYADH, 28 June — The Ministry of Health in Saudi Arabia approved the Pfizer-BioNTech COVID-19 vaccine in the country for children aged 12 to 18 to ramp up the vaccination in the kingdom, reported Saudi Gazette.
The Pfizer COVID vaccine was authorised for use in Saudi Arabia for people aged 18 and above back in December 2020 by the Saudi Food and Drug Authority (SFDA).
The SFDA has now amended the authorisation for the vaccine to include children aged 12 to 18.
It announced that those wishing to register their children to receive the vaccine could do so by booking an appointment through the Sehaty and Tawakkalna applications.
The Ministry said it had administered more than 17.2 million vaccine doses through 587 vaccination centres across the Kingdom, covering 70 per cent of the total adult population in Saudi Arabia.
Sources: Saudi Gazette/Agencies
